Stock Offerings – Page 2

Hoth Therapeutics Inc. Announces Pricing of Initial Public Offering and Trading on the Nasdaq Capital Market Under the Ticker Symbol “HOTH”

NEW YORK, Feb. 15, 2019 (GLOBE NEWSWIRE) — Hoth Therapeutics Inc. (“Hoth” or the “Company”), a development stage biopharmaceutical...

Stealth BioTherapeutics Announces Pricing of Initial Public Offering

BOSTON, Feb. 14, 2019 /PRNewswire/ — Stealth BioTherapeutics (Stealth), a clinical-stage biotechnology company focused on the discovery, development and commercialization...

Alight files Form S-1 registration statement for proposed initial public offering

LINCOLNSHIRE, Ill., Feb. 14, 2019 /PRNewswire/ — Alight Inc., a leader in technology-enabled health, wealth, and human capital management...

Bluerock Value Exchange Reports Fast Sellout of Maryland Class A Multifamily 1031 Exchange Offering

NEW YORK, Feb. 14, 2019 /PRNewswire/ — Bluerock Value Exchange (“BVEX”) announced today the full subscription of its latest 1031 exchange...

Cibus Postpones Initial Public Offering

SAN DIEGO, Feb. 14, 2019 /PRNewswire/ — Cibus, a leader in advanced plant-breeding technologies, today announced it has postponed plans...

Forbes Announces Commencement Of Rights Offering

ALICE, Texas, Feb. 14, 2019 /PRNewswire/ — Forbes Energy Services Ltd. (OTCQX: FLSS) (“Forbes” or the “Company”) is distributing to...

Inovio Pharmaceuticals Prices $65.0 Million Convertible Senior Notes Offering

PLYMOUTH MEETING, Pa., Feb. 14, 2019 /PRNewswire/ — Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today the pricing of its offering...

Arix Bioscience plc: Harpoon Closes Initial Public Offering

LONDON, February 14, 2019 /PRNewswire/ — This Announcement Contains Inside Information Within The Meaning Of The EU Market Abuse...

Avedro Announces Pricing of Initial Public Offering

WALTHAM, Mass., Feb. 13, 2019 (GLOBE NEWSWIRE) — Avedro, Inc. (Nasdaq: AVDR) (“Avedro”), a leading commercial-stage ophthalmic medical technology...

TCR2 Therapeutics Announces Pricing of Initial Public Offering of Common Stock

CAMBRIDGE, Mass., Feb. 13, 2019 /PRNewswire/ — TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage immunotherapy company developing the next...